121 related articles for article (PubMed ID: 35381788)
21. Clinicopathologic features of primary and postirradiation cerebral gliosarcoma.
Perry JR; Ang LC; Bilbao JM; Muller PJ
Cancer; 1995 Jun; 75(12):2910-8. PubMed ID: 7773942
[TBL] [Abstract][Full Text] [Related]
22. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens.
Feldkamp MM; Lala P; Lau N; Roncari L; Guha A
Neurosurgery; 1999 Dec; 45(6):1442-53. PubMed ID: 10598712
[TBL] [Abstract][Full Text] [Related]
23. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
Nguyen HN; Lie A; Li T; Chowdhury R; Liu F; Ozer B; Wei B; Green RM; Ellingson BM; Wang HJ; Elashoff R; Liau LM; Yong WH; Nghiemphu PL; Cloughesy T; Lai A
Neuro Oncol; 2017 Mar; 19(3):394-404. PubMed ID: 27571882
[TBL] [Abstract][Full Text] [Related]
24. The prognostic impact of O6-methylguanine DNA methyltransferase and epidermal growth factor receptor expressions on primary gliosarcoma: a clinicopathologic and immunohistochemical study of seven cases at a single institution.
Lin JW; Wu YT; Chang IW
Indian J Pathol Microbiol; 2011; 54(4):683-7. PubMed ID: 22234090
[TBL] [Abstract][Full Text] [Related]
25. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
[TBL] [Abstract][Full Text] [Related]
26. Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian Population.
Trabelsi S; Chabchoub I; Ksira I; Karmeni N; Mama N; Kanoun S; Burford A; Jury A; Mackay A; Popov S; Bouaouina N; Ben Ahmed S; Mokni M; Tlili K; Krifa H; Yacoubi MT; Jones C; Saad A; H'mida Ben Brahim D
Mol Neurobiol; 2017 May; 54(4):2381-2394. PubMed ID: 26957305
[TBL] [Abstract][Full Text] [Related]
27. Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.
Pratt D; Pittaluga S; Palisoc M; Fetsch P; Xi L; Raffeld M; Gilbert MR; Quezado M
J Neuropathol Exp Neurol; 2017 Aug; 76(8):697-708. PubMed ID: 28789475
[TBL] [Abstract][Full Text] [Related]
28. Contribution of histiocytic cells to sarcomatous development of the gliosarcoma. An immunohistochemical study.
Kochi N; Budka H
Acta Neuropathol; 1987; 73(2):124-30. PubMed ID: 3111162
[TBL] [Abstract][Full Text] [Related]
29. Gliosarcoma with osteosarcomatous component: A case report and short review illustration.
Chen Y; Zhou S; Zhou X; Dai X; Wang L; Chen P; Zhao S; Shi C; Xiao S; Dong J
Pathol Res Pract; 2022 Apr; 232():153837. PubMed ID: 35278815
[TBL] [Abstract][Full Text] [Related]
30. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
Smith DR; Wu CC; Saadatmand HJ; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; Wang SH; Canoll P; McKhann GM; Wang TJC
J Neurooncol; 2018 Apr; 137(2):303-311. PubMed ID: 29264835
[TBL] [Abstract][Full Text] [Related]
31. BRAF
Wang W; Wang M; Jiang H; Wang T; Da R
BMC Neurol; 2021 May; 21(1):195. PubMed ID: 33980169
[TBL] [Abstract][Full Text] [Related]
32. An autopsy case of primary gliosarcoma with multiple extracranial metastases: pathology after administration of bevacizumab and genetic profile.
Sato Y; Deguchi S; Norose T; Oishi T; Mitsuya K; Sugino T; Akiyama Y; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Hayashi N; Yamaguchi K
Nagoya J Med Sci; 2023 Nov; 85(4):828-835. PubMed ID: 38155632
[TBL] [Abstract][Full Text] [Related]
33. Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database.
Frandsen J; Orton A; Jensen R; Colman H; Cohen AL; Tward J; Shrieve DC; Suneja G
J Neurosurg; 2018 Apr; 128(4):1133-1138. PubMed ID: 28621623
[TBL] [Abstract][Full Text] [Related]
34. Telomerase activity and hTERT mRNA expression in glial tumors.
Boldrini L; Pistolesi S; Gisfredi S; Ursino S; Ali G; Pieracci N; Basolo F; Parenti G; Fontanini G
Int J Oncol; 2006 Jun; 28(6):1555-60. PubMed ID: 16685456
[TBL] [Abstract][Full Text] [Related]
35. [Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma].
Wang DL; Wang YF; Shi GS; Huang H
Ai Zheng; 2007 Jun; 26(6):601-6. PubMed ID: 17562265
[TBL] [Abstract][Full Text] [Related]
36. A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter.
Komata T; Koga S; Hirohata S; Takakura M; Germano IM; Inoue M; Kyo S; Kondo S; Kondo Y
Int J Oncol; 2001 Nov; 19(5):1015-20. PubMed ID: 11605003
[TBL] [Abstract][Full Text] [Related]
37. Gliosarcoma: an immunohistochemical, ultrastructural and fluorescence in situ hybridization study.
Horiguchi H; Hirose T; Kannuki S; Nagahiro S; Sano T
Pathol Int; 1998 Aug; 48(8):595-602. PubMed ID: 9736406
[TBL] [Abstract][Full Text] [Related]
38. Postirradiated and nonirradiated gliosarcoma: immunophenotypical profile.
Ang LC; Perry JR; Bilbao JM; Ozane W; Peschke E; Young B; Nelson N
Can J Neurol Sci; 1996 Nov; 23(4):251-6. PubMed ID: 8951202
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival.
Kiviniemi A; Gardberg M; Frantzén J; Parkkola R; Vuorinen V; Pesola M; Minn H
J Neurooncol; 2015 Sep; 124(2):237-45. PubMed ID: 26033547
[TBL] [Abstract][Full Text] [Related]
40. Glial cell line-derived neurotrophic factor (GDNF) and its receptor (GFR-alpha 1) are strongly expressed in human gliomas.
Wiesenhofer B; Stockhammer G; Kostron H; Maier H; Hinterhuber H; Humpel C
Acta Neuropathol; 2000 Feb; 99(2):131-7. PubMed ID: 10672319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
